Cuprina Holdings Receives MEDIFLY Product Classification in Saudi Arabia
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2026
0mins
Cuprina Holdings announced several strategic business developments, including a significant regulatory classification in Saudi Arabia and the expansion of its Medical and Scientific Advisory Board. Cuprina's 49%-owned associate, Cuprina MENA Co. Ltd, has received official product classification from the Saudi Food and Drug Authority for MEDIFLY, the Company's medical-grade maggot debridement therapy. The SFDA has classified MEDIFLY as a Medical Device-Drug combination product, with the primary mode of action regulated under the medical device framework. This classification, which allows the Company to finalize the scientific and technical requirements necessary for the commercial distribution of MEDIFLY across Saudi Arabia's healthcare network, is a critical milestone in Cuprina's expansion strategy for the Middle East and North Africa region. The Company is also pleased to announce the appointment of Enming Yong to its Medical and Scientific Advisory Board. Dr. Yong is a highly respected Consultant in the Department of Endocrinology at Tan Tock Seng Hospital and serves as an Adjunct Senior Lecturer at the Lee Kong Chian School of Medicine, both located in Singapore.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CUPR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CUPR
About CUPR
Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company, which is engaged in the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. Its segments include Maggot Debridement Therapy Product (MDT) and Cosmeceutical Product. It manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as MDT, which is an effective alternative to surgical debridement. It has two lines of chronic wound care products in its pipeline, such as Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus) and products utilizing medical leeches for wound treatment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cuprina Plans 1-for-8 Share Consolidation
- Share Consolidation Plan: Cuprina announced a 1-for-8 share consolidation effective May 27, 2026, aiming to regain compliance with Nasdaq Marketplace Rules by converting every eight Class A and Class B ordinary shares into one Class A ordinary share, thereby maintaining its Nasdaq Capital Market listing.
- Trading Symbol Unchanged: Post-consolidation, the company's Class A ordinary shares will continue trading on Nasdaq under the same symbol "CUPR" but will have a new CUSIP number G2592E110, facilitating investor tracking and identification of the stock.
- Strategic Importance: Cuprina's CEO David Quek stated that this consolidation is a crucial step towards maintaining their Nasdaq listing and enhancing the company's long-term financial flexibility, reflecting a proactive approach to future growth.
- Market Reaction Anticipation: By implementing the share consolidation, Cuprina expects to improve its stock market performance, potentially attracting more investor interest and laying a foundation for future growth.
See More
Cuprina to Implement 1-for-8 Share Consolidation
- Share Consolidation Plan: Cuprina Holdings announced a 1-for-8 share consolidation effective May 27, 2026, aimed at regaining compliance with Nasdaq listing requirements, thereby enhancing the company's capital market position.
- Trading Details: Post-consolidation, the Class A ordinary shares will trade under a new CUSIP number G2592E110 on the Nasdaq Capital Market, with every 8 shares converting into 1 share, ensuring no change in shareholders' percentage interests.
- Board Approval: The share consolidation plan was approved by the board on April 21, 2026, and received shareholder support during the annual meeting on May 14, indicating strong backing for the company's capital market strategy.
- CEO Statement: Cuprina's CEO David Quek stated that this action is a crucial step toward maintaining Nasdaq listing and enhancing long-term financial flexibility, supporting the ongoing advancement of its biomedical and collagen-based technology portfolio.
See More
Schall Law Firm Investigates Cuprina Holdings for Securities Violations
- Investigation Launched: The Schall Law Firm has announced an investigation into Cuprina Holdings (NASDAQ:CUPR), focusing on whether the company issued false or misleading statements that may have harmed investors' rights.
- Investor Rights Protection: This investigation aims to safeguard investors who suffered losses due to potential violations of securities laws by Cuprina Holdings, with the firm encouraging affected shareholders to participate and discuss their rights.
- Legal Services Offered: The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, providing free legal consultations to help investors understand their rights in this case.
- Advertising Disclosure: This press release may be considered attorney advertising in certain jurisdictions, underscoring the firm's professionalism and commitment to investor advocacy.
See More
Super Copper Corp Raises $2 Million in Brokered Private Placement
- Funding Size: Super Copper Corp. announces a brokered private placement aiming to raise up to $2 million by issuing 2,666,666 units at a price of $0.75 per unit, demonstrating the company's proactive capital-raising capabilities in the market.
- Use of Proceeds: The funds will be utilized to advance two copper projects in Chile (Cordillera Cobre and Castilla), including completing magnetic and Induced Polarization surveys to identify potential ore targets, thereby enhancing the development potential of these projects.
- Underwriting Arrangement: The offering is led by A.G.P. Canada Investments ULC and Baader Bank AG, with a cash commission of 6% of the gross proceeds, indicating strong market confidence and support for Super Copper.
- Compliance and Transparency: The offering will comply with Canadian Securities Exchange regulations, with related documents made available on the company's website and SEDAR+, ensuring investors have access to comprehensive information before making investment decisions.
See More
Nasdaq Faces Challenges with Small IPOs as Regulators Intensify Oversight.
- Nasdaq's IPO Leadership: Nasdaq is the leading U.S. stock exchange for initial public offerings (IPOs), hosting more than any other exchange.
- High Rate of Failed IPOs: The exchange is also known for a significant number of small IPOs that fail, resulting in substantial losses for public investors.
See More
Cuprina Receives Nasdaq Noncompliance Notice Due to Bid Price Below $1
- Stock Price Warning: Cuprina Holdings received a noncompliance notice from Nasdaq due to its closing bid price failing to meet the $1 minimum requirement over the last 30 trading days, indicating significant market pressure on the company.
- Compliance Period: The company has a 180-day compliance period to regain its bid price, and if it achieves a closing price of at least $1 for ten consecutive days, it can avoid delisting, highlighting the urgency for Cuprina to act swiftly to ensure continued listing.
- Potential Consequences: If compliance is not regained within the specified timeframe, Cuprina may need to consider measures such as a reverse stock split to meet Nasdaq's other listing standards, reflecting the company's vulnerability in the capital markets.
- Ongoing Trading: Despite the warning, Cuprina's shares will continue to trade, indicating that the market remains cautious yet hopeful about the company's efforts to regain compliance in the future.
See More
Cuprina Plans 1-for-8 Share Consolidation
- Share Consolidation Plan: Cuprina announced a 1-for-8 share consolidation effective May 27, 2026, aiming to regain compliance with Nasdaq Marketplace Rules by converting every eight Class A and Class B ordinary shares into one Class A ordinary share, thereby maintaining its Nasdaq Capital Market listing.
- Trading Symbol Unchanged: Post-consolidation, the company's Class A ordinary shares will continue trading on Nasdaq under the same symbol "CUPR" but will have a new CUSIP number G2592E110, facilitating investor tracking and identification of the stock.
- Strategic Importance: Cuprina's CEO David Quek stated that this consolidation is a crucial step towards maintaining their Nasdaq listing and enhancing the company's long-term financial flexibility, reflecting a proactive approach to future growth.
- Market Reaction Anticipation: By implementing the share consolidation, Cuprina expects to improve its stock market performance, potentially attracting more investor interest and laying a foundation for future growth.
See More
Cuprina to Implement 1-for-8 Share Consolidation
- Share Consolidation Plan: Cuprina Holdings announced a 1-for-8 share consolidation effective May 27, 2026, aimed at regaining compliance with Nasdaq listing requirements, thereby enhancing the company's capital market position.
- Trading Details: Post-consolidation, the Class A ordinary shares will trade under a new CUSIP number G2592E110 on the Nasdaq Capital Market, with every 8 shares converting into 1 share, ensuring no change in shareholders' percentage interests.
- Board Approval: The share consolidation plan was approved by the board on April 21, 2026, and received shareholder support during the annual meeting on May 14, indicating strong backing for the company's capital market strategy.
- CEO Statement: Cuprina's CEO David Quek stated that this action is a crucial step toward maintaining Nasdaq listing and enhancing long-term financial flexibility, supporting the ongoing advancement of its biomedical and collagen-based technology portfolio.
See More
Schall Law Firm Investigates Cuprina Holdings for Securities Violations
- Investigation Launched: The Schall Law Firm has announced an investigation into Cuprina Holdings (NASDAQ:CUPR), focusing on whether the company issued false or misleading statements that may have harmed investors' rights.
- Investor Rights Protection: This investigation aims to safeguard investors who suffered losses due to potential violations of securities laws by Cuprina Holdings, with the firm encouraging affected shareholders to participate and discuss their rights.
- Legal Services Offered: The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, providing free legal consultations to help investors understand their rights in this case.
- Advertising Disclosure: This press release may be considered attorney advertising in certain jurisdictions, underscoring the firm's professionalism and commitment to investor advocacy.
See More
Super Copper Corp Raises $2 Million in Brokered Private Placement
- Funding Size: Super Copper Corp. announces a brokered private placement aiming to raise up to $2 million by issuing 2,666,666 units at a price of $0.75 per unit, demonstrating the company's proactive capital-raising capabilities in the market.
- Use of Proceeds: The funds will be utilized to advance two copper projects in Chile (Cordillera Cobre and Castilla), including completing magnetic and Induced Polarization surveys to identify potential ore targets, thereby enhancing the development potential of these projects.
- Underwriting Arrangement: The offering is led by A.G.P. Canada Investments ULC and Baader Bank AG, with a cash commission of 6% of the gross proceeds, indicating strong market confidence and support for Super Copper.
- Compliance and Transparency: The offering will comply with Canadian Securities Exchange regulations, with related documents made available on the company's website and SEDAR+, ensuring investors have access to comprehensive information before making investment decisions.
See More
Nasdaq Faces Challenges with Small IPOs as Regulators Intensify Oversight.
- Nasdaq's IPO Leadership: Nasdaq is the leading U.S. stock exchange for initial public offerings (IPOs), hosting more than any other exchange.
- High Rate of Failed IPOs: The exchange is also known for a significant number of small IPOs that fail, resulting in substantial losses for public investors.
See More
Cuprina Receives Nasdaq Noncompliance Notice Due to Bid Price Below $1
- Stock Price Warning: Cuprina Holdings received a noncompliance notice from Nasdaq due to its closing bid price failing to meet the $1 minimum requirement over the last 30 trading days, indicating significant market pressure on the company.
- Compliance Period: The company has a 180-day compliance period to regain its bid price, and if it achieves a closing price of at least $1 for ten consecutive days, it can avoid delisting, highlighting the urgency for Cuprina to act swiftly to ensure continued listing.
- Potential Consequences: If compliance is not regained within the specified timeframe, Cuprina may need to consider measures such as a reverse stock split to meet Nasdaq's other listing standards, reflecting the company's vulnerability in the capital markets.
- Ongoing Trading: Despite the warning, Cuprina's shares will continue to trade, indicating that the market remains cautious yet hopeful about the company's efforts to regain compliance in the future.
See More
